This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (31)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A. GENE PETERSEN, M.D.; MARK DODGE, M.D.; FERDINAND C. HELWIG, M.D.

AMA Arch Intern Med. 1959;103(2):285-288.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since 1953 several reports of pulmonary lesions developing concurrently with hexamethonium therapy for hypertension have been recorded. The lesions have been described as similar but not always identical to acute diffuse interstitial pulmonary fibrosis as described by Hamman and Rich.¹

In 1953, Morrison ² reported 39 cases of hypertension treated with parenteral hexamethonium, with the development of dyspnea and bilateral symmetrical opacities on chest roentgenograms in three patients treated for 7, 9, and 15 months, respectively. One of these patients died, and autopsy revealed extensive central carnification of both lungs. A subsequent report by Doniach, Morrison, and Steiner,³ apparently on the same three patients, showed both an intra-alveolar and an interstitial pulmonary fibrosis in the two patients who died. One atient recovered, with improvement as observed in the chest x-ray.

Morrow, Schroeder, and Perry⁴ mention five cases of hypertension treated with hexamethonium and hydralazine in which interstitial . . . [Full Text PDF of this Article]

Author Affiliations
Kansas City, Mo.

From the Departments of Pathology and Medicine, St. Luke's Hospital.

Footnotes
Submitted for publication July 16, 1958.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?